Elimination kinetics of plasma exchange.
Interest in the therapeutic use of plasma exchange for various diseases is growing. The two different effects of plasma exchange are elimination and activation. The kinetics are linear for elimination by plasma exchange, but not for activation. Plasma exchange is performed intermittently and can be described by intermittent kinetics. According to intermittent kinetics, plasma exchange removes 50% to 75% of a substance in plasma within 1-2 h, corresponding to an elimination half-life of 30-40 min. Hybrid kinetics, a mixture of actually intermittent but theoretically continuous elimination by plasma exchange, can however also be applied. Hybrid kinetics are more convenient and more reliable than intermittent kinetics. This is because hybrid kinetics are based solely on the concentrations before each plasma exchange; hybrid kinetics also reflect removal from the entire body and not just from the plasma compartment. According to hybrid kinetics, the amount of a substance in the body removed within 3-4 days is 50% of the difference between the initial and the final plasma concentration, depending on the intensity of plasma exchange. The intensity may well contribute at least in part to the beneficial effect of plasma exchange in various diseases.
D000906:Antibodies / Q000032:analysis; D000936:Antigen-Antibody Complex / Q000032:analysis; D002784:Cholesterol / Q000032:analysis; D003165:Complement System Proteins / Q000032:analysis; D004077:Digoxin / Q000097:blood; D005340:Fibrinogen / Q000032:analysis; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007700:Kinetics; D012157:Mononuclear Phagocyte System / Q000502:physiology*; D010951:Plasma Exchange; D011950:Receptors, Cholinergic / Q000276:immunology
D000906:Antibodies; D000936:Antigen-Antibody Complex; D007136:Immunoglobulins; D011950:Receptors, Cholinergic; D004077:Digoxin; D005340:Fibrinogen; D003165:Complement System Proteins; D002784:Cholesterol